Kolexia
Seror Olivier
Radio-diagnostic
Hôpital Jean Verdier
Bondy, France
129 Activités
270 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Carcinome hépatocellulaire Carcinomes Tumeurs du foie Fibrose Récidive tumorale locale Cirrhose du foie Maladies du foie Cirrhose alcoolique Nécrose

Industries

QUANTUM SURGICAL
6 collaboration(s)
Dernière en 2021
GE Healthcare
5 collaboration(s)
Dernière en 2023
Boston Scientific
2 collaboration(s)
Dernière en 2023
Roche
2 collaboration(s)
Dernière en 2021

Dernières activités

Long-term oncological results of percutaneous radiofrequency ablation for intrahepatic cholangiocarcinoma.
Liver international : official journal of the International Association for the Study of the Liver   04 mars 2024
Association of LI-RADS and Histopathologic Features with Survival in Patients with Solitary Resected Hepatocellular Carcinoma.
Radiology   28 février 2024
Incidence and clinical impact of bile ducts changes after multibipolar radiofrequency ablation for hepatocellular carcinoma.
European radiology   09 février 2024
Impact of radiological response and pattern of progression in patients with hepatocellular carcinoma treated by atezolizumab- bevacizumab.
Hepatology (Baltimore, Md.)   23 octobre 2023
DUMELEP: Durvalumab/Tremelimumab in Neoadjuvant and Adjuvant Setting in Patients With HCC Treated by Electroporation Ablation in Curative Intent: French Multicenter Phase 2 Therapeutic
Essai Clinique (AstraZeneca)   13 septembre 2023
Dynamic evolution of circulating tumor DNA in patients with hepatocellular carcinoma across tumor stages and treatments
Abstracts of the A.I.S.F. - Italian Association for the Study of the Liver Monothematic Conference “Liver oncology: from basic science to liver transplantation" Padua, September 28th-29th, 2023   01 septembre 2023
Molecular-based targeted therapies in patients with hepatocellular carcinoma and hepato-cholangiocarcinoma refractory to atezolizumab/bevacizumab.
Journal of hepatology   28 août 2023
Sulfatase 2 Along with Syndecan 1 and Glypican 3 Serum Levels are Associated with a Prognostic Value in Patients with Alcoholic Cirrhosis-Related Advanced Hepatocellular Carcinoma.
Journal of hepatocellular carcinoma   28 décembre 2022
Imaging and histological features of tumor biopsy sample predict aggressive intrasegmental recurrence of hepatocellular carcinoma after radiofrequency ablation.
Scientific reports   04 novembre 2022
Impact of sarcopenia on tumor response and survival outcomes in patients with hepatocellular carcinoma treated by trans-arterial (chemo)-embolization.
World journal of gastroenterology   04 octobre 2022